Replies to post #5089 on **The Average Joes**

[Lone Wolf]

Moving now: FLRE - Daily Candlesticks

[PoemStone]

CXM. DD. 1st higher lows after New Volume:



Generx®
Angiogenic Therapy PDF 10-18-2011
http://phx.corporate-ir.net/External.File?item=UGFyZW50SUQ9NDQzNDYzfENoaWxkSUQ9NDY2MDYwfFR5cGU9MQ==&t=1

Seeking AlPha - Buy rating:
http://seekingalpha.com/article/298799-buy-and-sell-ideas-based-on-monday-s-big-biotech-news-movers?source=yahoo

Announced 10-10-2011 that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market and sell the Company's new Excellagen™ professional-use, sterile, syringe-based advanced wound care product for the management of diabetic foot ulcers and other dermal wounds..
http://ih.advfn.com/p.php?pid=nmona&article=49480240

A full PipeLine of Drugs: Home Website:
http://www.cardiumthx.com/index.html



The Big Ticket Winner is still ahead of them:



Generx Cardio-Chant Drug, Not Surgery based Treatment
for cardio vascular disease: a DNA-based angiogenic growth factor therapeutic being developed for the potential treatment of patients with advanced coronary artery disease.

A line of Skin Care & Supplements: MEDPODIUM:
http://www.medpodium.com/



10-Q [8-15-2011]
200,000,000 shares authorized; issued and outstanding 83,097,967 at June 30, 2011 and December 31, 2010 Float N/A.
"We anticipate that negative cash flow from operations will continue for 2011. Although we believe that we have sufficient capital to support our operations through January 1, 2012,"
"As of June 30, 2011, we had $3,182,919 in cash and cash equivalents and $1,325,000 in restricted cash"
http://ih.advfn.com/p.php?pid=nmona&article=48838354

iHub: http://ih.advfn.com/p.php?pid=squote&symbol=CXM

[WakingBake]

ACTN - WOW